NCT03652857View on ClinicalTrials.gov

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2019

Conditions
Advanced Non Small Cell Lung Cancer
Interventions
DRUG

Apatinib Combined With Vinorelbine

Vinorelbine 60mg/m2 d1qweek , Apatinib 500mg po Qd,evaluate every 2months

Trial Locations (1)

410013

Hunan Provincal Tumor Hospital, Changsha

All Listed Sponsors
lead

Yongchang Zhang

OTHER

NCT03652857 - Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter